New avenues developed by Mayo Clinic research

Alzheimer; News from the web:

Alzheimer’s disease relentlessly targets large-scale brain networks that support the formation of new memories. However, it remains a mystery as to why the disease selectively targets memory-related brain networks and how this relates to misfolded proteins seen by pathologists at autopsy. In an effort to bridge the divide between the targeted memory systems and the misfolded proteins and dying cells underneath, Mayo Clinic researchers have turned to the field of complex systems — an emerging field of science that studies how parts of systems give rise to collective behaviors and how the system interacts with its environment.

Read all about it HERE

Alzheimer’s caused by your overactive immune system?

Alzheimer; News from the web:

A new study conducted by researchers from the University of Southampton in England found that reducing brain inflammation could be the key to treat and prevent Alzheimer’s disease. Lead author of the study, Dr. Diego Gomez-Nicola, confirmed they have found a way “into tackling the disease” and have to move the learnings to a clinical setup as soon as possible. Contrary to the belief that Alzheimer’s caused brain inflammation, the study found that it is an overactive immune system, which inflames the brain, potentially leading to the disease.

Read all about it HERE

Lumosity in trouble with the FTC

Alzheimer; News from the web:

Remember that game on your phone that would help you prevent Alzheimer’s or Dementia? Well now they have had to settle with the FTC for a large amount because they could not substantiate with research the claims that the marketing department had made.

“Going forward, a key focus of our ongoing research is to build on these studies to better understand how training-driven improvements on tests of cognition translate to performance in participants’ everyday lives,” the company said.

Read all about it HERE

EPPS seen as effective against Alzheimer’s

Alzheimer; News from the web:

Scientists tested a chemical called EPPS on mice that had been genetically engineered to contract a disease similar to Alzheimer’s in humans from five months of age. The researchers found that the amount of plaques characteristic in the brain had been reduced in the treated mice.

Read all about it HERE